Analyst Ratings for Cerevel Therapeutics (CERE) [Sells]
CERE Rating Summary
CERE Price Target Summary
- Highest: $45.00 (Piper Sandler)
- Lowest: $30.00 (Goldman Sachs)
- Average: $40.75
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$40.75 (-3.3%)
* Over Last 12-Mos
Rating Score: 2.8 / 10 Percentile Rank: 23%
Rating Score: 2.8 / 10 Percentile Rank: 23%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|